FDA Approves Twice-Yearly Injectable to Prevent HIV
The FDA has approved a first ever twice-yearly injectable regimen for HIV prevention in adults and adolescents, offering an effective alternative to daily PrEP.
More Videos
Consumers Expect to Curb Summer Fun—But Spending Tells a Different Story
Ted Rossman, Senior Industry Analyst at Bankrate, joins J.D. Durkin to discuss the disconnect between consumer sentiment and spending. Watch!
Are U.S.-China Trade Relations Showing Improvement?
Jeremy Jansen, Head of Supply Chain at Wells Fargo, unpacks the ongoing trade talks between the United States and China as consumers still wonder about tariffs.
IBM Gears Up for First Quantum‑Centric Supercomputer in 2025
IBM Fellow Jerry Chow talks IBM’s expansion of the Quantum Data Center in Poughkeepsie, installing Heron processors that deliver utility‑scale performance.
The Future of Fertility: How AI Is Transforming the Way Couples Conceive
Doctors report the first successful pregnancy using AI to find hidden sperm, marking a major fertility breakthrough, reports TIME’s Alice Park.
Go Fund Yourself: A New Safety Wearable + Making Solar Power More Accessible
Why iByte might save your life. Plus, how Energy ReLeaf is making solar power more accessible.
Trump Family Crypto Empire: A Web of Millions, Influence, and Ethical Concerns
Sam Blum, Senior Writer at Inc. Magazine, discusses one of his latest articles on why the Trump family is embracing crypto. Watch!
